Dr. Hsia reported reductions in 3 DUX4 target genes in human FSHD myotubes treated with 8 nM of the FM10-TfR antibody Fab fragment conjugate. The gene discussed is TFRC; the disease is facioscapulohumeral muscular dystrophy.